Skip to main content
PMC home page
The Ulster Medical Journal logoLink to The Ulster Medical Journal
editorial
. 2001 Nov;70(2):79–88.

Insurance, genetic testing and familial cancer: recent policy changes in the United Kingdom.

P J Morrison
PMCID: PMC2449245  PMID: 11795771

Full text

PDF
79

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hall M. A., Rich S. S. Laws restricting health insurers' use of genetic information: impact on genetic discrimination. Am J Hum Genet. 2000 Jan;66(1):293–307. doi: 10.1086/302714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Harper P. S. Genetic testing and insurance. J R Coll Physicians Lond. 1992 Apr;26(2):184–187. [PMC free article] [PubMed] [Google Scholar]
  3. Harper P. S. Insurance and genetic testing. Lancet. 1993 Jan 23;341(8839):224–227. doi: 10.1016/0140-6736(93)90080-z. [DOI] [PubMed] [Google Scholar]
  4. Hodgson S., Milner B., Brown I., Bevilacqua G., Chang-Claude J., Eccles D., Evans G., Gregory H., Møller P., Morrison P. Cancer genetics services in Europe. Dis Markers. 1999 Oct;15(1-3):3–13. doi: 10.1155/1999/134945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Huggins M., Bloch M., Kanani S., Quarrell O. W., Theilman J., Hedrick A., Dickens B., Lynch A., Hayden M. Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington disease. Am J Hum Genet. 1990 Jul;47(1):4–12. [PMC free article] [PubMed] [Google Scholar]
  6. Low L., King S., Wilkie T. Genetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom. BMJ. 1998 Dec 12;317(7173):1632–1635. doi: 10.1136/bmj.317.7173.1632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MacDonald A. S. How will improved forecasts of individual lifetimes affect underwriting? Philos Trans R Soc Lond B Biol Sci. 1997 Aug 29;352(1357):1067–1075. doi: 10.1098/rstb.1997.0087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Morrison P. J. Genetic testing and insurance in the United Kingdom. Clin Genet. 1998 Nov;54(5):375–379. doi: 10.1111/j.1399-0004.1998.tb03749.x. [DOI] [PubMed] [Google Scholar]
  9. Morrison P. J. Implications of genetic testing for insurance in the UK. Lancet. 1998 Nov 21;352(9141):1647–1648. doi: 10.1016/s0140-6736(05)61446-8. [DOI] [PubMed] [Google Scholar]
  10. Morrison P. J., Steel C. M., Vasen H. F., Eccles D., Evans D. G., Møller P., Hodgson S., Stoppa-Lyonnet D., Chang-Claude J., Caligo M. Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe. Dis Markers. 1999 Oct;15(1-3):159–165. doi: 10.1155/1999/748254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Norum J., Tranebjaerg L. Health, life and disability insurance and hereditary risk for breast or colorectal cancer. Acta Oncol. 2000;39(2):189–193. doi: 10.1080/028418600430752. [DOI] [PubMed] [Google Scholar]
  12. Schoonmaker M. M., Bernhardt B. A., Holtzman N. A. Factors influencing health insurers' decisions to cover new genetic technologies. Int J Technol Assess Health Care. 2000 Winter;16(1):178–189. doi: 10.1017/s026646230016115x. [DOI] [PubMed] [Google Scholar]
  13. Thompson J. A., Wiesner G. L., Sellers T. A., Vachon C., Ahrens M., Potter J. D., Sumpmann M., Kersey J. Genetic services for familial cancer patients: a survey of National Cancer Institute cancer centers. J Natl Cancer Inst. 1995 Oct 4;87(19):1446–1455. doi: 10.1093/jnci/87.19.1446. [DOI] [PubMed] [Google Scholar]
  14. Tyler A., Morris M., Lazarou L., Meredith L., Myring J., Harper P. Presymptomatic testing for Huntington's disease in Wales 1987-90. Br J Psychiatry. 1992 Oct;161:481–488. doi: 10.1192/bjp.161.4.481. [DOI] [PubMed] [Google Scholar]
  15. Vasen H. F., Haites N. E., Evans D. G., Steel C. M., Møller P., Hodgson S., Eccles D., Morrison P., Stoppa Lyonet D., Chang-Claude J. Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. Eur J Cancer. 1998 Nov;34(12):1922–1926. doi: 10.1016/s0959-8049(98)00288-3. [DOI] [PubMed] [Google Scholar]
  16. Wadman M. Privacy bill under fire from researchers. Nature. 1998 Mar 5;392(6671):6–6. doi: 10.1038/32004. [DOI] [PubMed] [Google Scholar]
  17. Zick C. D., Smith K. R., Mayer R. N., Botkin J. R. Genetic testing, adverse selection, and the demand for life insurance. Am J Med Genet. 2000 Jul 3;93(1):29–39. [PubMed] [Google Scholar]

Articles from The Ulster Medical Journal are provided here courtesy of Ulster Medical Society

RESOURCES